ResMed Inc. develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing.  The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors.

Current Report (Form 8-K | Period ending 2024-11-20)

Current Report (Form 8-K | Period ending 2024-10-24)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Resmed Inc (RMD US)

Current Report (Form 8-K | Period ending 2024-11-20)

Current Report (Form 8-K | Period ending 2024-10-24)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Annual Report to Security Holders (Form ARS | Period ending 2024-06-30)

Current Report (Form 8-K | Period ending 2024-08-15)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)